| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.18T | 1.12T | 1.10T | 1.01T | 910.23B | 875.93B |
| Gross Profit | 326.59B | 323.31B | 307.82B | 281.59B | 256.47B | 225.38B |
| EBITDA | 183.49B | 174.89B | 157.54B | 135.19B | 115.04B | 85.13B |
| Net Income | 85.33B | 92.24B | 75.35B | 61.35B | 58.66B | 41.93B |
Balance Sheet | ||||||
| Total Assets | 1.38T | 1.31T | 1.27T | 1.18T | 1.12T | 1.05T |
| Cash, Cash Equivalents and Short-Term Investments | 70.34B | 63.54B | 66.19B | 84.70B | 92.97B | 76.55B |
| Total Debt | 103.86B | 101.29B | 160.35B | 180.63B | 206.82B | 215.03B |
| Total Liabilities | 585.67B | 581.51B | 609.70B | 609.48B | 593.38B | 590.70B |
| Stockholders Equity | 752.59B | 691.77B | 602.52B | 517.09B | 472.90B | 417.00B |
Cash Flow | ||||||
| Free Cash Flow | 51.45B | 68.17B | 17.90B | 55.08B | 43.76B | 6.35B |
| Operating Cash Flow | 128.66B | 144.92B | 84.86B | 116.16B | 76.81B | 26.93B |
| Investing Cash Flow | -89.42B | -63.38B | -62.42B | -49.50B | -22.35B | 23.58B |
| Financing Cash Flow | -32.55B | -86.25B | -45.87B | -77.19B | -42.89B | -39.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥3.22T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% | |
73 Outperform | ¥635.02B | 8.10 | 9.63% | 2.12% | 3.05% | -16.11% | |
72 Outperform | ¥9.88T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
71 Outperform | ¥12.21T | 21.58 | 9.29% | 1.19% | 4.62% | 40.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥1.63T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
55 Neutral | ¥1.28T | 40.59 | 8.39% | 1.49% | -2.18% | 30.16% |